FI946103A - Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi ja sitä sisältävä farmaseuttinen koostumus - Google Patents

Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi ja sitä sisältävä farmaseuttinen koostumus Download PDF

Info

Publication number
FI946103A
FI946103A FI946103A FI946103A FI946103A FI 946103 A FI946103 A FI 946103A FI 946103 A FI946103 A FI 946103A FI 946103 A FI946103 A FI 946103A FI 946103 A FI946103 A FI 946103A
Authority
FI
Finland
Prior art keywords
igg
adsorbent
plasma
immunoglobulin
concentrate
Prior art date
Application number
FI946103A
Other languages
English (en)
Swedish (sv)
Other versions
FI946103A0 (fi
FI112168B (fi
Inventor
Gerhard Hodler
Peter Lerch
Martin Stucki
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI946103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of FI946103A0 publication Critical patent/FI946103A0/fi
Publication of FI946103A publication Critical patent/FI946103A/fi
Application granted granted Critical
Publication of FI112168B publication Critical patent/FI112168B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI946103A 1993-12-27 1994-12-27 Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi FI112168B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810912 1993-12-27
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält

Publications (3)

Publication Number Publication Date
FI946103A0 FI946103A0 (fi) 1994-12-27
FI946103A true FI946103A (fi) 1995-06-28
FI112168B FI112168B (fi) 2003-11-14

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946103A FI112168B (fi) 1993-12-27 1994-12-27 Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi

Country Status (20)

Country Link
US (1) US5593675A (fi)
EP (1) EP0659767B2 (fi)
JP (1) JP2926463B2 (fi)
KR (1) KR100368563B1 (fi)
AT (1) ATE175979T1 (fi)
AU (1) AU682243B2 (fi)
CA (1) CA2138921C (fi)
CZ (1) CZ286271B6 (fi)
DE (1) DE59309332D1 (fi)
DK (1) DK0659767T4 (fi)
ES (1) ES2129076T5 (fi)
FI (1) FI112168B (fi)
GR (1) GR3029817T3 (fi)
HU (1) HU216864B (fi)
NO (1) NO315331B1 (fi)
NZ (1) NZ278057A (fi)
PL (1) PL180358B1 (fi)
SI (1) SI9420008B (fi)
TW (1) TW311884B (fi)
WO (1) WO1995018155A1 (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU760048B2 (en) * 1998-05-06 2003-05-08 Genentech Inc. Protein purification by ion exchange chromatography
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
CA2607281C (en) * 2005-05-05 2023-10-03 Duke University Anti-cd19 antibody therapy for autoimmune disease
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
EP2061803B2 (en) * 2006-08-28 2022-11-16 Ares Trading S.A. Process for the purification of fc-containing proteins
US20100267932A1 (en) * 2006-08-28 2010-10-21 Alex Eon-Duval Process for the purification of fc-fusion proteins
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
PL2531218T3 (pl) 2010-02-04 2019-05-31 Csl Behring Ag Preparat immunoglobuliny
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
US8795658B2 (en) * 2010-09-17 2014-08-05 Baxter International Inc. Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
CN103874708B (zh) * 2011-08-26 2018-07-10 百深有限责任公司 用于降低血浆来源免疫球蛋白组合物的血栓栓塞可能性的方法
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
ES2785375T3 (es) * 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
PL310435A1 (en) 1995-12-11
DK0659767T3 (da) 1999-09-13
US5593675A (en) 1997-01-14
JPH07206708A (ja) 1995-08-08
PL180358B1 (pl) 2001-01-31
WO1995018155A1 (en) 1995-07-06
AU1414395A (en) 1995-07-17
NO945032D0 (no) 1994-12-23
HU216864B (hu) 1999-09-28
EP0659767A1 (de) 1995-06-28
FI946103A0 (fi) 1994-12-27
KR960701098A (ko) 1996-02-24
DK0659767T4 (da) 2003-02-10
ES2129076T3 (es) 1999-06-01
JP2926463B2 (ja) 1999-07-28
SI9420008B (sl) 1998-06-30
ES2129076T5 (es) 2003-05-16
GR3029817T3 (en) 1999-06-30
CA2138921A1 (en) 1995-06-28
CZ286271B6 (cs) 2000-03-15
TW311884B (fi) 1997-08-01
DE59309332D1 (de) 1999-03-04
HU9502514D0 (en) 1995-11-28
FI112168B (fi) 2003-11-14
EP0659767B2 (de) 2002-11-06
NO945032L (no) 1995-06-28
KR100368563B1 (ko) 2003-04-03
AU682243B2 (en) 1997-09-25
CA2138921C (en) 2004-11-02
ATE175979T1 (de) 1999-02-15
CZ249295A3 (en) 1996-01-17
NO315331B1 (no) 2003-08-18
NZ278057A (en) 1997-03-24
HUT73376A (en) 1996-07-29
SI9420008A (en) 1996-02-29
EP0659767B1 (de) 1999-01-20

Similar Documents

Publication Publication Date Title
FI946103A (fi) Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi ja sitä sisältävä farmaseuttinen koostumus
GR3025504T3 (en) Protein purification method
EP0352500A3 (en) Polyclonal immunoglobulin-based intravenous preparation with a high igm content, and method for its production
MX9707909A (es) Purificacion de anticuerpos.
AU638969B2 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
AU7067287A (en) Method and apparatus for separating proteins
EP0530447A3 (en) Process for purifying igg monoclonal antibodies and their use
EP0385118A3 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
DE3914869C1 (fi)
EP0087686A3 (en) Homogeneous human immune interferon and process therefor
DE3479503D1 (en) Process for the preparation of an antithrombin iii-heparin, e.g. an antithrombin iii-heparinoid concentrate
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
DE4229876A1 (de) Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
IL124952A0 (en) Method for the production of rdspa alpha1 pharmaceutical compositions containing the same and use thereof
RU95112503A (ru) Способ выделения предварительно отобранного гемоглобина и очищенный препарат гемоглобина
EP0766697A1 (de) Verfahren zur isolierung von isolektinen aus der mistel
DD285113A5 (de) Verfahren zur gewinnung von reinem menschlichen wachstumshormon (hgh)
HK1007747A1 (en) Interferon purification process
AU5095990A (en) A method for cleansing streptokinases
GB9001593D0 (en) Thiophilic absorbents
FI935161A (fi) Menetelmä plasmaproteiinien TTR ja RBP eristämiseksi ja jatkopuhdistamiseksi
RU93009368A (ru) Способ получения микрогранулированной целлюлозы, сорбенты на ее основе для выделения и очистки ферментных препаратов и способ очистки стрептокиназы

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ZLB BEHRING AG

Free format text: ZLB BEHRING AG

PC Transfer of assignment of patent

Owner name: CSL BEHRING AG

Free format text: CSL BEHRING AG

MM Patent lapsed